Cera™ Vascular Plug System Post-Market Clinical Follow-Up
Cera™ Vascular Plug System Post-Market Clinical Follow-Up: A Multi-center, Prospective, Observational, Single-arm, Open-label, Post-market Study
Lifetech Scientific (Shenzhen) Co., Ltd.
132 participants
Jun 21, 2024
OBSERVATIONAL
Conditions
Summary
The objective of the study is to collect and evaluate clinical data on patients of the Lifetech Cera™ Vascular Plug System to: * confirm the performance * confirm the safety * identify previously unknown side-effects * monitor the identified side-effects (related to the procedures or to the medical devices) * identify and analyse emergent risks
Eligibility
Inclusion Criteria6
- Aged 18 to 85;
- Life expectancy \> 1 year;
- Require arterial or venous embolization in the peripheral vasculature;
- Target embolization site(s) allow for safe insertion of the delivery catheter;
- Voluntarily sign and date the Informed Consent Form (ICF) prior to any study-related activities commencement;
- Willing and able to comply with protocol requirements, including all study visits and procedures.
Exclusion Criteria10
- The subject is pregnant or plan to be pregnant or breast feeding;
- The subject has a known allergy or hypersensitivity to any of the device materials including: nickel, stainless steel, polytetrafluoroethylene and titanium nitride;
- The subject has a known allergy or hypersensitivity to contrast agent;
- The subject has uncorrectable coagulopathy;
- The subject has planned use of anticoagulant (e.g. direct thrombin inhibitors, factor Xa inhibitors, vitamin K antagonists) or antiplatelet therapy before, during and/or after treatment with the study device, which, in the opinion of the Investigator, would clinically interfere with the study endpoints
- The subject has an unresolved systemic infection;
- Subject who cannot tolerate general or local anesthesia;
- The subject has a connective tissue disorders (e.g. Ehlers-Danlos Syndrome), arteritis (e.g. Takayasu's Disease) or another circulatory disorder;
- The subject is participating in other drug or medical device clinical trials;
- Any condition (medical or anatomic) making the subject not suitable for transcatheter embolotherapy according to the opinion of the investigator.
Interventions
The Cera™ Vascular Plug System is composed of Cera™ Vascular Plug and its accessory Introducer Kit. The Cera™ Vascular Plug is a self-expandable, cylindrical Ni-Ti wire mesh device.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06099015